15 Amendments of José Inácio FARIA related to 2014/2207(INI)
Amendment 48 #
Motion for a resolution
Recital M a (new)
Recital M a (new)
Ma. whereas vaccination is an effective way to reduce the threat of antibacterial resistance by preventing infections that would need treatment with antibacterials and thereby reducing development of resistance;
Amendment 79 #
Motion for a resolution
Recital Q
Recital Q
Q. whereas it is of paramount importance to encourage pharmaceutical companies to invest in developing new antibiotic compounds, in particular with activity against by creating new market models that incentivise preivalent multidrug-resistant Gram-negative bacteria such as K. pneumoniae and Acinetobacterte investment in R&D, while preserving the sustainability of national health systems;
Amendment 128 #
Motion for a resolution
Paragraph 6 – point c
Paragraph 6 – point c
c) ensure appropriate training of doctors and other healthcare professionals, as well as exchange of best practices, and set up monitoring systems to verify that their competences are up-to-date with hospital hygiene practices and the technology in place;
Amendment 194 #
Motion for a resolution
Paragraph 18
Paragraph 18
18. Regrets that the past 25 years have witnessed both a lack of awareness of the importance of rational use of antimicrobial agents, and antibiotics in particular, and a stagnation in drug development in the field of antimicrobial medicines, which is linked to scientific, regulatory and economic challenges;
Amendment 211 #
Motion for a resolution
Paragraph 20
Paragraph 20
20. Considers it of paramount importance that the Commission should ensure the continuation of the EU Action Plan on Antimicrobial Resistance post-2017, withemphasising how to overcome the scientific, regulatory and emphasis onconomic challenges associated with antimicrobial resistance, while including the prevention and control of healthcare-associated infections;
Amendment 237 #
Motion for a resolution
Paragraph 22 – point a
Paragraph 22 – point a
a) regulate the prescription of antibiotics for treatment or prophylaxis so that an appropriate use of medicines is ensured, specifying the therapeutic objective and selecting the appropriate drug therapy; strictly implement responsible marketing practices avoiding conflict of interest between producers and prescribers;
Amendment 240 #
Motion for a resolution
Paragraph 22 – point a a (new)
Paragraph 22 – point a a (new)
aa) encourage the development of new revenue models whereby economic returns for companies are de-linked from prescribed volumes of antibiotics, while encouraging pharmaceutical innovation and balancing it with the sustainability of health systems;
Amendment 264 #
Motion for a resolution
Paragraph 22 – point f
Paragraph 22 – point f
f) launch awareness campaigns on the rational use of antibiotics and the risks entailed by increasing antibiotic resistance; these campaigns should address parents and carers responsible for young children as well as elderly people, and should always be followed by an assessment of their outcomes; highlights the opportunities offered by on-line health systems in this regard;
Amendment 268 #
Motion for a resolution
Paragraph 22 – point f a (new)
Paragraph 22 – point f a (new)
fa) increase the incentive for research and development of new antimicrobials;
Amendment 285 #
Motion for a resolution
Paragraph 23 – point b
Paragraph 23 – point b
b) Introduce legal tools to restrict the use of antibiotics in animals if a significant risk to public health is identified and ensure that adequate monitoring and effective enforcement mechanisms are in place;
Amendment 287 #
Motion for a resolution
Paragraph 23 – point b a (new)
Paragraph 23 – point b a (new)
ba) launch awareness campaigns on the responsible use of antimicrobials for animals, including pets;
Amendment 301 #
Motion for a resolution
Paragraph 24
Paragraph 24
24. Urges the Member States to regulate any conflicts of interest and financial incentive involving veterinarians who both sell and prescribe antibiotics;
Amendment 315 #
Motion for a resolution
Paragraph 25 – indent 2 b (new)
Paragraph 25 – indent 2 b (new)
- to prohibit on-line sale of antimicrobials;
Amendment 323 #
Motion for a resolution
Paragraph 26 a (new)
Paragraph 26 a (new)
26a. Calls on the Member States and the Commission to start a reflection process together with the WHO to develop a new economic model, that de-links the volume of antibiotics sales from the reward paid for a new antibiotic, ensuring a fair return on investment for the companies, while safeguarding the sustainability of national health systems;
Amendment 326 #
Motion for a resolution
Paragraph 27
Paragraph 27
27. Encourages pharmaceutical company partnersies, governments and academia to contribute with their best assets (compounds and ideas) toinfrastructure, compounds, ideas and financial resources) to ground-breaking fundamental research and pre-competitive joint projects; believes that the Innovative Medicine Initiative (IMI) should be given the flexibility to explore any new findings emerging from those projects;